Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who wrote (1912)	9/29/1997 9:48:00 PM
From: Larry Liebman	of 6136

So, I called Agouron. To paraphrase the company response: "We are clueless as to why Montgomery downgraded Agouron, particularly in light of the extremely positive news presented today". It appears that most of the IR dept. was in Toronto and had not anticipated anything but support for the stock. I continue to hold a position in Agouron, having held for several years, selling pieces on the way up. I wonder when the investment community will respond to the claim that they intend to put 2 drugs into clinical trials per year for the forseeable future. Viracept is an important product, but the pipeline has always been the lure for me. I will call the company tomorrow to see if IR has more to contribute. For those unaccustomed to AGPH swings, take a look at the chart over 2 years.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next